Search Results Search Sort by RelevanceMost Recent Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Podcast Jul 2022 Ethics Talk: Illuminating the Science of Art Artist and researcher Dr Mark Gilbert joins Ethics Talk to discuss arts-based research: what it is, who it’s for, and why we should pay closer attention to it as a method of clinical inquiry. Original Research Jul 2022 Arts-Based Research Methods to Explore Cancer in Indigenous Communities Aislinn C. Rookwood, MPH, Mariah Abney, Hannah S. Butler-Robbins, Danielle Marie Westmark, MLIS, and Regina Idoate, PhD Culturally responsive, arts-based methods can enhance research and education across the cancer-control continuum with Indigenous persons. AMA J Ethics. 2022;24(7):E563-575. doi: 10.1001/amajethics.2022.563. Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. Case and Commentary Aug 2023 Should Organizational Investment in Robotic Surgical Technology Ever Influence Surgeons’ Decisions About Surgical Approach to Patients’ Surgical Care? Ryan D. Rosen, DO and David A. Edelman, MD, MSHPEd Costs partly determine organizational robotics, but questions remain about whether and to what extent they should influence care decisions. AMA J Ethics. 2023;25(8):E575-582. doi: 10.1001/amajethics.2023.575. Case and Commentary Aug 2023 How Should Risk Be Communicated to Patients When Developing Resident Surgeon Robotic Skills? Matthew C. Bobel, MD and Robert K. Cleary, MD This article suggests strategies for how to disclose the nature and scope of resident surgeon involvement in managing intraoperative care. AMA J Ethics. 2023;25(8):E583-588. doi: 10.1001/amajethics.2023.583. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Next page Next › Last page Last »
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Podcast Jul 2022 Ethics Talk: Illuminating the Science of Art Artist and researcher Dr Mark Gilbert joins Ethics Talk to discuss arts-based research: what it is, who it’s for, and why we should pay closer attention to it as a method of clinical inquiry.
Original Research Jul 2022 Arts-Based Research Methods to Explore Cancer in Indigenous Communities Aislinn C. Rookwood, MPH, Mariah Abney, Hannah S. Butler-Robbins, Danielle Marie Westmark, MLIS, and Regina Idoate, PhD Culturally responsive, arts-based methods can enhance research and education across the cancer-control continuum with Indigenous persons. AMA J Ethics. 2022;24(7):E563-575. doi: 10.1001/amajethics.2022.563.
Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Apr 2021 How Should Compassion Be Expressed as a Primary Clinical and Ethical Value in Anorexia Nervosa Intervention? Melissa Lavoie, MD and Angela S. Guarda, MD For an adolescent patient with extreme anorexia nervosa, steps for expressing compassion during a force intervention need to be clear. AMA J Ethics. 2021;23(4):E298-304. doi: 10.1001/amajethics.2021.298.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.
Case and Commentary Aug 2023 Should Organizational Investment in Robotic Surgical Technology Ever Influence Surgeons’ Decisions About Surgical Approach to Patients’ Surgical Care? Ryan D. Rosen, DO and David A. Edelman, MD, MSHPEd Costs partly determine organizational robotics, but questions remain about whether and to what extent they should influence care decisions. AMA J Ethics. 2023;25(8):E575-582. doi: 10.1001/amajethics.2023.575.
Case and Commentary Aug 2023 How Should Risk Be Communicated to Patients When Developing Resident Surgeon Robotic Skills? Matthew C. Bobel, MD and Robert K. Cleary, MD This article suggests strategies for how to disclose the nature and scope of resident surgeon involvement in managing intraoperative care. AMA J Ethics. 2023;25(8):E583-588. doi: 10.1001/amajethics.2023.583.